Open Access

Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45‑ depletion and RNA extraction

  • Authors:
    • Dae‑Dong Kim
    • Chun‑Seok Yang
    • Hyun‑Dong Chae
    • Sang‑Gyu Kwak
    • Chang‑Ho Jeon
  • View Affiliations

  • Published online on: May 22, 2017     https://doi.org/10.3892/ol.2017.6226
  • Pages: 837-843
  • Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A total of 76 blood samples from patients without malignant disease and 107 blood samples from patients with malignant disease were investigated for the presence of circulating tumor cells (CTCs). To detect CTCs, hematopoietic cells were removed from the blood samples and different RNA extraction methods were used to amplify the melanoma antigen‑encoding gene family member A1‑family member A6 (MAGE A1‑6) and the human telomerase reverse transcriptase (hTERT) gene as potential CTC markers. Comparison between four methods for extracting RNA from the blood was performed. The samples were enriched by cluster of differentiation 45 (CD45) antibody capturing, and the reverse transcription‑quantitative polymerase chain reaction was used to amplify the MAGE A1‑6 and hTERT genes. MAGE A1‑6 and hTERT gene expression levels were also evaluated in 14 cancer cell lines, and the MAGE A1‑6 and hTERT expression levels were 85.7 and 100%, respectively. The RNeasy method demonstrated the most sensitivity in the SNU1 cells mixed with blood, although the differences between methods was non‑significant. The positive expression levels of MAGE A1‑6 and hTERT was 11.8% in the control group and 58.9% in those with malignant disease. In the 70 patients with colorectal cancer, positive expression levels of MAGE A1‑6 or hTERT were significantly higher in stages T3 and T4 compared with in stages T1 and T2. The CTC detection method involving CD45 antibody capture, RNA extraction and MAGE A1‑6 and hTERT reverse transcription resulted in good rates of sensitivity and specificity. Thus, the present study concluded that MAGE A1‑6 and hTERT genes may be potential and practical markers for CTCs in a clinical setting.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kim DD, Yang CS, Chae HD, Kwak SG and Jeon CH: Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45‑ depletion and RNA extraction. Oncol Lett 14: 837-843, 2017
APA
Kim, D., Yang, C., Chae, H., Kwak, S., & Jeon, C. (2017). Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45‑ depletion and RNA extraction. Oncology Letters, 14, 837-843. https://doi.org/10.3892/ol.2017.6226
MLA
Kim, D., Yang, C., Chae, H., Kwak, S., Jeon, C."Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45‑ depletion and RNA extraction". Oncology Letters 14.1 (2017): 837-843.
Chicago
Kim, D., Yang, C., Chae, H., Kwak, S., Jeon, C."Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45‑ depletion and RNA extraction". Oncology Letters 14, no. 1 (2017): 837-843. https://doi.org/10.3892/ol.2017.6226